RetractedArticleOncoTargets and therapy2016

MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET.

Haosheng Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.